BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effects of dietary fibre source on microbiota composition in the large intestine of suckling piglets. ✅
FEMS microbiology letters (FEMS Microbiol Lett ) Vol: 363 Issue 14 Pages: Pub: 2016 Jul Epub: 2016 May 25 Authors Zhang L , Mu C , He X , Su Y , Mao S , Zhang J , Smidt H , Zhu W , |
|
|
The Role of Carrageenan and Carboxymethylcellulose in the Development of Intestinal Inflammation. ✅
Go to Publication ✅
Frontiers in pediatrics (Front Pediatr ) Vol: 5 Issue Pages: 96 Pub: 2017 Epub: 2017 May 1 Authors Martino JV , Van Limbergen J , Cahill LE , |
|
|
Protective effect of cellulose and soluble dietary fiber from Saccharina japonica by-products on regulating inflammatory responses, gut microbiota, and SCFAs production in colitis mice. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: Issue Pages: 131214 Pub: 2024 Apr 3 Epub: 2024 Apr 3 Authors Cao J , Qin L , Zhang L , Wang K , Yao M , Qu C , Miao J , |
|
|
Bacterial cellulose is a desirable biological macromolecule that can prevent obesity via modulating lipid metabolism and gut microbiota. ✅
Go to Publication ✅
International journal of biological macromolecules (Int J Biol Macromol ) Vol: 283 Issue Pt 1 Pages: 137522 Pub: 2024 Nov 12 Epub: 2024 Nov 12 Authors Han YH , Cui XW , Li YX , Chen X , Zhang H , Zhang Y , Wang SS , Li M , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
